ANG-3070

· Angion Biomedica Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANG-3070, covering 2022-03-23 to 2022-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease [Phase 2]